Autoantibodies as predictors of pregnancy complications

Clicks: 482
ID: 114363
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 28 articles by views in rheumatology (oxford, england)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Certain autoantibodies which are found in autoimmune diseases including CTDs can impair fertility. Reproductive failure may present as pregnancy loss, either as miscarriage, intrauterine fetal death or stillbirth. There are also late obstetric complications such as intrauterine growth restriction, p …
Reference Key
hj2008rheumatologyautoantibodies Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Carp HJ;Meroni PL;Shoenfeld Y;;
Journal rheumatology (oxford, england)
Year 2008
DOI
DOI not found
URL
https://www.pubmed.gov/18504286/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine pregnancy models female Animal Autoimmune Diseases / immunology* pregnancy outcome Abortion pregnancy complications / immunology* habitual / immunology fetal growth retardation / immunology biomarkers / blood pmid:18504286 doi:10.1093/rheumatology/ken154 h j a carp p l meroni y shoenfeld autoantibodies / blood* obstetric labor premature / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.